ADC Therapeutics SA - stock earnings
ADCT Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 6, 2024 AfterMarket | - / -0.5668000000 | - | - / 18.6 million | - |
ADCT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -85.0 million USD | 16.8 million USD |
| 2023Q3 | -47.8 million USD | 14.5 million USD |
| 2023Q2 | -47.1 million USD | 19.3 million USD |
| 2023Q1 | -59.4 million USD | 19.0 million USD |
| 2022Q4 | -24.2 million USD | 69.8 million USD |
| 2022Q3 | -50.6 million USD | 76.3 million USD |
| 2022Q2 | -64.4 million USD | 17.3 million USD |
| 2022Q1 | -16.7 million USD | 46.5 million USD |
| 2021Q4 | -34.4 million USD | 17.0 million USD |
| 2021Q3 | -71.5 million USD | 13.1 million USD |
| 2021Q2 | -72.6 million USD | 3.8 million USD |
| 2021Q1 | -51.5 million USD | ? USD |
| 2020Q4 | -55.9 million USD | 51.9 million USD |
| 2020Q3 | -20.3 million USD | ? USD |
| 2020Q2 | -126.6 million USD | ? USD |
| 2020Q1 | -43.5 million USD | ? USD |
| 2019Q4 | -35.3 million USD | ? USD |
| 2019Q3 | -31.3 million USD | ? USD |
| 2019Q2 | -23.3 million USD | 2.0 million USD |
| 2019Q1 | -24.9 million USD | 1.2 million USD |
| 2018Q4 | -123.1 million USD | 1.1 million USD |
| 2018Q2 | -61.8 million USD | 625000 USD |
| 2018Q1 | -30.9 million USD | 312500 USD |
| 2010Q3 | 10.6 million USD | 312.6 million USD |
| 2010Q2 | 75.8 million USD | 304.4 million USD |
| 2010Q1 | ? USD | 274.0 million USD |
| 2009Q4 | ? USD | 265.6 million USD |
| 2009Q2 | ? USD | 283.4 million USD |
| 2009Q1 | ? USD | 275.1 million USD |
| 2008Q4 | ? USD | 254.3 million USD |
| 2008Q3 | ? USD | 352.3 million USD |
| 2008Q2 | 15.1 million USD | 381.8 million USD |
| 2008Q1 | 16.3 million USD | 393.2 million USD |
| 2007Q4 | ? USD | 329.1 million USD |
| 2007Q3 | ? USD | 329.5 million USD |
| 2007Q2 | 16.6 million USD | 346.1 million USD |
| 2007Q1 | 92.1 million USD | 349.4 million USD |
| 2006Q4 | 3.6 million USD | 297.2 million USD |
| 2006Q3 | 40.1 million USD | 307.4 million USD |
| 2006Q2 | 4.6 million USD | 343.6 million USD |
| 2006Q1 | 22.8 million USD | 358.1 million USD |
| 2005Q4 | ? USD | 272.8 million USD |
| 2005Q3 | 900000 USD | 294.0 million USD |
| 2005Q2 | 23.9 million USD | 305.6 million USD |
| 2005Q1 | 33.4 million USD | 288.8 million USD |
| 2004Q4 | 52.5 million USD | 241.0 million USD |
| 2004Q3 | 59.7 million USD | 263.5 million USD |
| 2004Q2 | ? USD | 224.9 million USD |
| 2004Q1 | ? USD | 148.3 million USD |
| 2003Q4 | ? USD | 136.7 million USD |
| 2003Q3 | 9.4 million USD | 154.5 million USD |
| 2003Q2 | ? USD | 129.8 million USD |
| 2003Q1 | ? USD | 110.5 million USD |
| 2002Q4 | ? USD | 194.6 million USD |
| 2002Q3 | ? USD | 220.8 million USD |
| 2002Q2 | ? USD | 235.1 million USD |
| 2002Q1 | ? USD | 298.3 million USD |
| 2001Q4 | ? USD | 293.5 million USD |
| 2001Q3 | ? USD | 391.6 million USD |
| 2001Q2 | ? USD | 547.5 million USD |
| 2001Q1 | ? USD | 652.4 million USD |
| 2000Q4 | ? USD | 811.3 million USD |
| 2000Q3 | 87.1 million USD | 1.0 billion USD |
| 2000Q2 | 9.7 million USD | 891.4 million USD |
| 2000Q1 | 718.2 million USD | 770.6 million USD |
| 1999Q4 | 53.1 million USD | 593.9 million USD |
ADCT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -240.1 million USD | 69.6 million USD |
| 2022 | -155.8 million USD | 209.9 million USD |
| 2021 | -230.0 million USD | 33.9 million USD |
| 2020 | -246.3 million USD | ? USD |
| 2019 | -116.5 million USD | 2.3 million USD |
| 2018 | -123.1 million USD | 1.1 million USD |
| 2017 | -89.9 million USD | 1.8 million USD |
| 2010 | 62.0 million USD | 1.2 billion USD |
| 2009 | ? USD | 996.7 million USD |
| 2008 | ? USD | 1.5 billion USD |
| 2007 | 106.3 million USD | 1.3 billion USD |
| 2006 | 65.7 million USD | 1.3 billion USD |
| 2005 | 110.7 million USD | 1.2 billion USD |
| 2004 | 16.4 million USD | 784.3 million USD |
| 2003 | ? USD | 773.2 million USD |
| 2002 | ? USD | 1.0 billion USD |
| 2001 | ? USD | 2.4 billion USD |
| 2000 | 868.1 million USD | 3.3 billion USD |
ADCT
Price: $4.90
52 week price:
Earnings Per Share: -2.94 USD
P/E Ratio: -1.65
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Volume: 1.0 million
Market Capitalization: 412.6 million